# Keros Therapeutics, Inc.: Form 8-K, filed Aug 3, 2026

- Company: [Keros Therapeutics, Inc.](/companies/kros.md) (CIK 1664710)
- Form: 8-K
- Filed: 2026-08-03
- Accepted by EDGAR: Aug 3, 2026, 16:02 ET
- Period: 2026-08-03
- Accession: 0001664710-26-000048
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1664710/000166471026000048/kros-20260803.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1664710/000166471026000048/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1664710/000166471026000048/kros-20260803.htm

Filed Aug 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001664710-26-000048. Last ingested by Listed: Nov 13, 2026, 14:49 ET. No prices; not investment advice.
